{
  "pmcid": "12122560",
  "sha256": "6c993ec42e3009fe6f4d379fc23f998cf999cca79cb0a0a35e7df299d13ae212",
  "timestamp_utc": "2025-11-09T23:27:11.048532+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.699400986610293,
    "reading_ease": 25.108847780126865,
    "word_count": 258
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Gastrointestinal Motility Agents in Elective Colorectal Surgery"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults undergoing elective colorectal surgery across various international settings."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Interventions included prokinetics and laxatives, compared to placebo or standard ERAS care."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assesses the efficacy and safety of GI motility agents in this setting."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was GI-2 recovery, defined as tolerance of solid diet and stool passage, measured within the first postoperative week."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation and allocation concealment methods varied across studies."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was implemented for patients and outcome assessors."
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The analysis was intention-to-treat."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "GI motility agents significantly accelerated GI-2 recovery (mean difference –1.01 days; 95% CI –1.29 to –0.73; p < 0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were not significantly different between groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: PROSPERO CRD420250655358."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}